ProPhase Labs Inc. (PRPH)
ProPhase Labs Statistics
Share Statistics
ProPhase Labs has 23.87M shares outstanding. The number of shares has increased by 32.3% in one year.
| Shares Outstanding | 23.87M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 25.14% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 20.54M |
| Failed to Deliver (FTD) Shares | 400 |
| FTD / Avg. Volume | 0.13% |
Short Selling Information
The latest short interest is 154.06K, so 0.65% of the outstanding shares have been sold short.
| Short Interest | 154.06K |
| Short % of Shares Out | 0.65% |
| Short % of Float | 0.75% |
| Short Ratio (days to cover) | 7.04 |
Valuation Ratios
The PE ratio is -4.63 and the forward PE ratio is 1.54.
| PE Ratio | -4.63 |
| Forward PE | 1.54 |
| PS Ratio | 1.75 |
| Forward PS | 0.1 |
| PB Ratio | 1.57 |
| P/FCF Ratio | -5.36 |
| PEG Ratio | n/a |
Enterprise Valuation
ProPhase Labs Inc. has an Enterprise Value (EV) of 97.01M.
| EV / Earnings | -5.78 |
| EV / Sales | 2.19 |
| EV / EBITDA | -6.54 |
| EV / EBIT | -4.49 |
| EV / FCF | -6.69 |
Financial Position
The company has a current ratio of 2.28, with a Debt / Equity ratio of 0.43.
| Current Ratio | 2.28 |
| Quick Ratio | 2.1 |
| Debt / Equity | 0.43 |
| Total Debt / Capitalization | 30.21 |
| Cash Flow / Debt | -0.53 |
| Interest Coverage | -16.95 |
Financial Efficiency
Return on equity (ROE) is -0.34% and return on capital (ROIC) is -22.48%.
| Return on Equity (ROE) | -0.34% |
| Return on Assets (ROA) | -0.18% |
| Return on Capital (ROIC) | -22.48% |
| Revenue Per Employee | 392.78K |
| Profits Per Employee | -148.51K |
| Employee Count | 113 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 7.33 |
Taxes
| Income Tax | -6.02M |
| Effective Tax Rate | 0.26 |
Stock Price Statistics
The stock price has increased by -90.59% in the last 52 weeks. The beta is -0.1, so ProPhase Labs 's price volatility has been lower than the market average.
| Beta | -0.1 |
| 52-Week Price Change | -90.59% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 31.51 |
| Average Volume (20 Days) | 308.64K |
Income Statement
In the last 12 months, ProPhase Labs had revenue of 44.38M and earned -16.78M in profits. Earnings per share was -0.98.
| Revenue | 44.38M |
| Gross Profit | 16.24M |
| Operating Income | -21.61M |
| Net Income | -16.78M |
| EBITDA | -14.83M |
| EBIT | -21.61M |
| Earnings Per Share (EPS) | -0.98 |
Balance Sheet
The company has 1.61M in cash and 21.38M in debt, giving a net cash position of -19.77M.
| Cash & Cash Equivalents | 1.61M |
| Total Debt | 21.38M |
| Net Cash | -19.77M |
| Retained Earnings | -5.03M |
| Total Assets | 91.81M |
| Working Capital | 13.54M |
Cash Flow
In the last 12 months, operating cash flow was -11.35M and capital expenditures -3.15M, giving a free cash flow of -14.50M.
| Operating Cash Flow | -11.35M |
| Capital Expenditures | -3.15M |
| Free Cash Flow | -14.50M |
| FCF Per Share | -0.84 |
Margins
Gross margin is 36.59%, with operating and profit margins of -48.7% and -37.81%.
| Gross Margin | 36.59% |
| Operating Margin | -48.7% |
| Pretax Margin | -51.37% |
| Profit Margin | -37.81% |
| EBITDA Margin | -33.41% |
| EBIT Margin | -48.7% |
| FCF Margin | -32.68% |
Dividends & Yields
PRPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -217.78% |
| FCF Yield | -136.48% |
Analyst Forecast
The average price target for PRPH is $11, which is 2344.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $11 |
| Price Target Difference | 2344.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Jan 23, 1997. It was a forward split with a ratio of 2:1.
| Last Split Date | Jan 23, 1997 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | -1.17 |
| Piotroski F-Score | 1 |